Pregnancy Screening for Women on Opioid Substitution Therapy
“Routine Pregnancy Screening for Women on Opioid Substitution Therapy”
Women who take opioid substitution therapy have higher rates of unintended pregnancy, more pregnancies, and a higher risk of pregnancy complications than the general population. Current practice is to test for pregnancy only at patient request or if the clinician suspects pregnancy. This study will compare monthly pregnancy testing to current practice in a double blind randomized control trial. As many women of childbearing age as possible will be recruited from the Hamilton Clinic for Opioid Substitutional Therapy. Women assigned to the intervention will have monthly testing at the same time as their monthly urine drug testing at the clinic. The primary objective is to assess if there is a significant difference is early pregnancy detection and the secondary objectives are to assess differences in pregnancy disposition and gestational age at entry to prenatal or abortion care.
Monthly Pregnancy Screening
Pregnancy test will be administered once per month during weekly urine testing for drug levels.
Routine Pregnancy Screening for Women on Opioid Substitution Therapy: A Randomized Controlled Trial